SouthGobi Resources Ltd. (SGQRF)
USD 0.3
(0.0%)
USD 0.3
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 167.31 Million | 26.13 Million | -4.32 Million | 22.91 Million | 32.56 Million | 40.42 Million |
| Net Income | 924.65 Thousand | -25.75 Million | -11.73 Million | -12.49 Million | 7.56 Million | -37.29 Million |
| Depreciation & Amortization | 6.33 Million | 3.84 Million | 6.06 Million | 9.81 Million | 16.5 Million | 32.26 Million |
| Deferred income taxes | 85.14 Million | -2.36 Million | -6.06 Million | -9.81 Million | -16.5 Million | - |
| Stock-based compensation | 14 Thousand | 161 Thousand | 203 Thousand | 113 Thousand | 47 Thousand | 79 Thousand |
| Change in working capital | 13.62 Million | 15.17 Million | -11.99 Million | -1.15 Million | -17.78 Million | 1.16 Million |
| Other non-cash items | 61.27 Million | 35.08 Million | 19.19 Million | 36.44 Million | 42.74 Million | 76.47 Million |
| Investing Cash Flow | -54.38 Million | -13.03 Million | -8.63 Million | -9.61 Million | -18.5 Million | -26.65 Million |
| Investments in PPE | -45.34 Million | -11.87 Million | -10.45 Million | -11.88 Million | -20.91 Million | -34.08 Million |
| Acquisitions | 45.82 Thousand | -1.99 Million | 1.32 Million | 268.47 Thousand | 9000.00 | -9000.00 |
| Investment purchases | -9.08 Million | -1.91 Million | - | - | -257.85 Thousand | -8541.03 |
| Sales/Maturities of investments | - | 1.91 Million | - | - | 257.85 Thousand | - |
| Other Investing Activities | -1.00 | 831 Thousand | 492.76 Thousand | 2 Million | 2.39 Million | 7.43 Million |
| Financing Cash Flow | -73.91 Million | -1.42 Million | -6.01 Million | -647 Thousand | -13.85 Million | -13.64 Million |
| Debt repayment | -73.45 Million | -373 Thousand | -3.12 Million | -647 Thousand | -1.46 Million | -5.89 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5091.69 | 26 Thousand | 11 Thousand | - | - | 11 Thousand |
| Other Financing Activities | -72.26 Million | -1.08 Million | -2.89 Million | -769 Thousand | -12.38 Million | -7.76 Million |
| Accounts receivables | -13.95 Million | -949.81 Thousand | 1.05 Million | -866.47 Thousand | 4.14 Million | -9.07 Million |
| Accounts payables | 533.6 Thousand | -2.56 Million | -7.6 Million | -13.09 Million | -8.56 Million | 33.04 Million |
| Inventory | -5.11 Million | 15.05 Million | -11.13 Million | 16.41 Million | -10.21 Million | -13.65 Million |
| Other working capital | 32.16 Million | 3.62 Million | 5.7 Million | -3.59 Million | -3.16 Million | 14.81 Million |
| Cash at beginning of period | 9.97 Million | 723 Thousand | 20.12 Million | 7.16 Million | 6.95 Million | 6.47 Million |
| Cash at end of period | 48.16 Million | 9.25 Million | 723 Thousand | 20.12 Million | 7.16 Million | 6.95 Million |
| Capital Expenditure | -45.34 Million | -11.87 Million | -10.45 Million | -11.88 Million | -20.91 Million | -34.08 Million |
| Effect of forex changes on cash | 430 Thousand | -3.14 Million | -422 Thousand | 299 Thousand | -5000.00 | 373 Thousand |
| Net cash flow / Change in cash | 38.19 Million | 8.53 Million | -19.39 Million | 12.95 Million | 205 Thousand | 488 Thousand |
| Free Cash Flow | 121.97 Million | 14.25 Million | -14.78 Million | 11.03 Million | 11.65 Million | 6.33 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.08 Million | 12.19 Million | 924.65 Thousand | 25 Million | 38.8 Million | -51.54 Million |
| Depreciation & Amortization | 3.64 Million | 2.46 Million | 6.33 Million | 1.75 Million | 1.62 Million | 1.45 Million |
| Deferred income taxes | - | - | 85.14 Million | 10.15 Million | -2000.00 | -1.45 Million |
| Stock-based compensation | 62 Thousand | 1000.00 | 14 Thousand | 2000.00 | 2000.00 | 15 Thousand |
| Change in working capital | 20.33 Million | -14.71 Million | 13.62 Million | 45.66 Million | 1.01 Million | -39.84 Million |
| Other non-cash items | 10.33 Million | -537.58 Thousand | 61.27 Million | 6.08 Million | 4.85 Million | 84.61 Million |
| Investing Cash Flow | -35.31 Million | -30.55 Million | -54.38 Million | -27.89 Million | -11.09 Million | -7.94 Million |
| Investments in PPE | -35.09 Million | -28.76 Million | -45.34 Million | -19.54 Million | -11.73 Million | -8.18 Million |
| Acquisitions | 982.79 Thousand | -1.8 Million | 45.82 Thousand | 94.61 | -357 Thousand | -363 Thousand |
| Investment purchases | -1.2 Million | -1.79 Million | -9.08 Million | -8.35 Million | -353.7 Thousand | -369.09 Thousand |
| Sales/Maturities of investments | - | - | - | - | 353.7 Thousand | - |
| Other Investing Activities | 777 Thousand | -1.03 Million | -1.00 | -0.61 | 996 Thousand | 602.09 Thousand |
| Financing Cash Flow | 2.85 Million | -3.18 Million | -73.91 Million | -50.21 Million | -13.15 Million | -10.08 Million |
| Debt repayment | -2.95 Million | -2.98 Million | -73.45 Million | -50.08 Million | -143 Thousand | -74 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 55.89 Thousand | 41.81 Thousand | 5091.69 | 10.51 | 1980.91 | 3050.35 |
| Other Financing Activities | -17 Thousand | -3.04 Million | -72.26 Million | -49.22 Million | -13.01 Million | -10.01 Million |
| Accounts receivables | 14.5 Million | -17.8 Million | -13.95 Million | -9.39 Million | 690.51 Thousand | -2.32 Million |
| Accounts payables | 8.08 Million | 28.31 Million | 533.6 Thousand | -5.33 Million | 6.31 Million | -4.03 Million |
| Inventory | -17.63 Million | -3.98 Million | -5.11 Million | 2.86 Million | 3.62 Million | -2.25 Million |
| Other working capital | 15.37 Million | -21.24 Million | 32.16 Million | 57.52 Million | -9.61 Million | -31.22 Million |
| Cash at beginning of period | 15.9 Million | 48.16 Million | 9.97 Million | 36.65 Million | 15.84 Million | 39.4 Million |
| Cash at end of period | 12.93 Million | 15.9 Million | 48.16 Million | 48.16 Million | 36.41 Million | 15.84 Million |
| Capital Expenditure | -35.09 Million | -28.76 Million | -45.34 Million | -19.54 Million | -11.73 Million | -8.18 Million |
| Effect of forex changes on cash | -362 Thousand | 257 Thousand | 430 Thousand | 1.26 Million | -1.46 Million | 1.23 Million |
| Net cash flow / Change in cash | -2.97 Million | -32.26 Million | 38.19 Million | 11.51 Million | 20.57 Million | -23.56 Million |
| Free Cash Flow | -5.2 Million | -27.76 Million | 121.97 Million | 69.12 Million | 34.55 Million | -14.93 Million |
PHARM
EACTF
SRS
5254
BA
CHMI-PA